Mary Ann Gray, Director at ACADIA PHARMACEUTICALS INC (ACAD), sold 12,250 shares at $31.74 ($389K) on 2014-12-15, disclosed to the SEC on 2014-12-17.
Scheduled sale ($389k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ACAD | SELL | 2013-08-28 | $310K | — | Filing → |
| GTCB | BUY | 2007-12-17 | $9K | — | Filing → |
| DYAX | BUY | 2006-05-19 | $29K | — | Filing → |